1-4 of 4
M. D. Minden
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Single Cell Network Profiles in Non-M3 AML Associated with Patient Response to Standard Induction Therapy.

Steven Kornblau, M.D., M. D. Minden, MD, PhD, David B. Rosen, PhD, Santosh Putta, PhD, Aileen C. Cohen, MD, PhD, Todd Covey, Wendy J. Fantl, PhD, Urte Gayko, PhD, Alessandra Cesano, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1582.
https://doi.org/10.1182/blood.V114.22.1582.1582
Published: 2009
Journal Articles

FLT3 ITD Signaling Profiles in AML Samples Harboring Mutations.

M. D. Minden, MD, PhD, Steven M. Kornblau, MD, David B. Rosen, PhD, Aileen Cleary Cohen, MD, PhD, Urte Gayko, PhD, Santosh Putta, PhD, John Woronicz, PhD, Wendy J. Fantl, PhD, Alessandra Cesano, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1588.
https://doi.org/10.1182/blood.V114.22.1588.1588
Published: 2009
Journal Articles

Classification of Acute Myeloid Leukemia (AML) Based On Apoptosis and Myeloid Signaling Networks.

David B. Rosen, PhD, M. D. Minden, MD, PhD, Santosh Putta, PhD, Todd Covey, Ying W. Huang, MSc, Alessandra Cesano, MD, PhD, Wendy J. Fantl, PhD
Journal: Blood
Blood (2009) 114 (22): 325.
https://doi.org/10.1182/blood.V114.22.325.325
Published: 2009
Journal Articles

Regulation of drug sensitivity by ribosomal protein S3a

Z.-B. Hu, M. D. Minden, E. A. McCulloch
Journal: Blood
Blood (2000) 95 (3): 1047–1055.
https://doi.org/10.1182/blood.V95.3.1047.003k43_1047_1055
Published: 2000